NIHON CHOUZAI Co.,Ltd.

Tokyo Stock Exchange 3341.T

NIHON CHOUZAI Co.,Ltd. Dividend Yield on February 07, 2025: 1.83%

NIHON CHOUZAI Co.,Ltd. Dividend Yield is 1.83% on February 07, 2025, a -4.54% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • NIHON CHOUZAI Co.,Ltd. 52-week high Dividend Yield is 2.15% on August 05, 2024, which is 17.33% above the current Dividend Yield.
  • NIHON CHOUZAI Co.,Ltd. 52-week low Dividend Yield is 0.01% on December 20, 2024, which is -99.34% below the current Dividend Yield.
  • NIHON CHOUZAI Co.,Ltd. average Dividend Yield for the last 52 weeks is 1.82%.
Key data
Date Dividend Yield Free Cash Flow Yield Earnings Yield Enterprise Value (EV)
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 3341.T

NIHON CHOUZAI Co.,Ltd.

CEO Mr. Naoto Kasai
IPO Date Sept. 17, 2004
Location Japan
Headquarters GranTokyo North Tower
Employees 5,864
Sector Healthcare
Industries
Description

Nihon Chouzai Co., Ltd. engages in the management of health insurance dispensing chain pharmacies in Japan. The company also manufactures and sells generic drugs to medical institutions and other pharmacies. In addition, it offers temporary staffing services for pharmacist; and employment services for physicians and registered sales personnel, and other healthcare professionals. Further, the company provides studies and research services for pharmaceutical companies and organizations; information and consulting services for industries associated with pharmaceuticals and healthcare; and other services. As of March 31, 2022, it had 697 stores. The company was incorporated in 1980 and is headquartered in Tokyo, Japan.

Similar companies

2201.T

Morinaga&Co., Ltd.

USD 17.30

-0.79%

3088.T

MatsukiyoCocokara & Co.

USD 14.63

0.41%

3034.T

Qol Holdings Co., Ltd.

USD 10.06

-1.25%

9989.T

Sundrug Co.,Ltd.

USD 26.82

-0.32%

3762.T

TechMatrix Corporation

USD 15.84

-0.12%

StockViz Staff

February 8, 2025

Any question? Send us an email